2022
DOI: 10.3390/molecules28010080
|View full text |Cite
|
Sign up to set email alerts
|

Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System

Abstract: Anthocyanins have been shown to be effective in chronic diseases because of their antioxidant and anti-inflammatory effects together with changes in the gut microbiota and modulation of neuropeptides such as insulin-like growth factor-1. This review will examine whether these mechanisms may be effective to moderate the symptoms of disorders of the central nervous system in humans, including schizophrenia, Parkinson’s disease, Alzheimer’s disease, autism spectrum disorder, depression, anxiety, attention-deficit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 131 publications
0
5
0
Order By: Relevance
“…Emerging evidence suggests a potential link between gut microbiota alterations and AD pathogenesis. Changes in gut microbiota composition may contribute to increased amyloid-β aggregation, neuroinflammation, and insulin resistance in the brain, further promoting oxidative stress ( Liu et al, 2020 ; Panchal and Brown, 2022 ).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Emerging evidence suggests a potential link between gut microbiota alterations and AD pathogenesis. Changes in gut microbiota composition may contribute to increased amyloid-β aggregation, neuroinflammation, and insulin resistance in the brain, further promoting oxidative stress ( Liu et al, 2020 ; Panchal and Brown, 2022 ).…”
Section: Resultsmentioning
confidence: 99%
“…According to studies, they can penetrate the blood-brain barrier ( Kalt et al, 2008 ) and anthocyanins may be able to prevent the cognitive deterioration that comes with age ( Andres-Lacueva et al, 2005 ; Spencer, 2010 ; Rehman et al, 2017 ; Wei et al, 2017 ). Beyond neuroprotection, anthocyanins are emerging as potential therapeutic agents for chronic CNS disorders due to their anti-inflammatory and antioxidant properties ( Panchal and Brown, 2022 ). Furthermore, studies indicate that anthocyanins may modulate gut microbiota, offering additional benefits in preventing cardiovascular and neurodegenerative diseases ( Winter and Bickford, 2019 ).…”
Section: Brain Agingmentioning
confidence: 99%
See 1 more Smart Citation
“…Considering the above, the determination of their content in juice obtained from new cultivars of colored‐flesh potatoes has been planned in the present study. However, based on the long‐lasting research of author's project (Panchal & Brown, 2022 ; Pęksa et al., 2013 ), it can be inferred that the contemporary potato cultivars intended for both processing and direct consumption have low levels of these compounds.…”
Section: Introductionmentioning
confidence: 99%
“…Anthocyanins have been shown to be effective in chronic diseases because of their antioxidant and anti-inflammatory effects together with changes in the gut microbiota and modulation of neuropeptides such as insulin-like growth factor-1. Therefore, Panchal and Brown [ 8 ] examined whether these mechanisms may be effective to moderate the symptoms of disorders of the central nervous system in humans, including schizophrenia, Parkinson’s disease, Alzheimer’s disease, autism spectrum disorder, depression, anxiety, attention-deficit hyperactivity disorder, and epilepsy. Thus, anthocyanins from fruits and berries should be considered as complementary interventions to improve these chronic disorders.…”
mentioning
confidence: 99%